SO
NWBO

STRS Ohio’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

STRS Ohio’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,100
Closed -$61K – 1905
2014
Q3 		$61K Hold
12,100
– – ﹤0.01% 1624
2014
Q2 		$81K Buy
+12,100
New +$77K ﹤0.01% 1580

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

STRS Ohio's NWBO Position: Q4 2014 in Review

STRS Ohio sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2014, closing a stake of 12,100 shares — an estimated $61K sold.

STRS Ohio first reported a position in NWBO in Q2 2014 and held it in 2 quarters. The position peaked at $81K in Q2 2014. 70 funds tracked by Wall St. Rank hold NWBO as of Q4 2014.

  • STRS Ohio reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2014 after selling out during the quarter.
  • STRS Ohio sold 12,100 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2014, an estimated $61K.
  • STRS Ohio first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 2 quarters.
  • STRS Ohio's Northwest Biotherapeutics, Inc. Common stock position peaked at $81K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2014.

Based on STRS Ohio's 13F filing for Q4 2014, filed 23 Jan 2015.